

Phunware, Inc.
Provides a fully integrated enterprise cloud platform for mobile. Its location based SaaS platform reaches over one billion unique devices per month for many Fortune 500 brands.
Research library
WallStreet Research has published hundreds of reports over five decades, distributed to over 200,000 investor subscribers worldwide. These are the reports and profiles featured online, covering emerging growth companies on NASDAQ, NYSE, AMEX, OTC Markets, TSX, CSE and global exchanges.


Provides a fully integrated enterprise cloud platform for mobile. Its location based SaaS platform reaches over one billion unique devices per month for many Fortune 500 brands.


A Tokyo based software development company offering SaaS products globally, plus data analytics that help enterprises create tailored web experiences.


Develops material handling solutions, and in 2021 introduced a new line of electric forklifts along with electric heavy industrial machinery such as front end loaders and excavators.


Designs, develops and sells conferencing, collaboration and network streaming solutions for voice and visual communications.


An emerging pharmaceuticals company developing novel, plant based, sustainably derived gastrointestinal products for markets around the world.


Formerly Newgioco Group, Inc. An international technology firm providing betting platforms for leisure gaming operators in Europe and the U.S., from lottery and casino gaming to sports betting.


Operates two business units: Mobile Energy Group, focused on commercial electric vehicles and their energy use, and Ideanomics Capital, which develops financial technology products and services.


Completed development of a medical grade software app prepared in compliance with ISO 13485 quality standards.
Supplies networked devices for wireless cashless payment in vending machines, laundry equipment, kiosks and more, along with energy management products. It has strategic relationships with MasterCard, Coca-Cola Enterprises, AT&T and First Data.
A biopharmaceutical company in New Jersey and Montreal developing therapeutic and diagnostic products for the aging population. It completed Phase II trials of its NX-1207 drug candidate for enlarged prostate and sells AlzheimAlert, a urine test that aids the diagnosis of Alzheimer's disease.
WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. Read the Disclaimer